Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NADPH-Ferrihemoprotein Reductase | 1 | 2025 | 4 | 0.890 |
Why?
|
| Lung Injury | 1 | 2025 | 126 | 0.780 |
Why?
|
| Hyperoxia | 1 | 2025 | 136 | 0.760 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 482 | 0.240 |
Why?
|
| Gene Editing | 1 | 2025 | 238 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 521 | 0.180 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2025 | 222 | 0.180 |
Why?
|
| Asthma | 2 | 2020 | 922 | 0.170 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2020 | 12 | 0.160 |
Why?
|
| Sodium Channels | 1 | 2020 | 97 | 0.150 |
Why?
|
| Sodium | 1 | 2020 | 280 | 0.150 |
Why?
|
| Infant, Premature | 1 | 2025 | 872 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 172 | 0.150 |
Why?
|
| Fish Oils | 1 | 2019 | 82 | 0.140 |
Why?
|
| Monocytes | 1 | 2020 | 335 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2019 | 82 | 0.140 |
Why?
|
| Heart Atria | 1 | 2020 | 343 | 0.130 |
Why?
|
| Action Potentials | 1 | 2020 | 476 | 0.130 |
Why?
|
| Heart Rate | 1 | 2020 | 577 | 0.130 |
Why?
|
| Inflammation | 2 | 2020 | 1489 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2019 | 448 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 668 | 0.110 |
Why?
|
| Animals | 6 | 2025 | 33912 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 999 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 4697 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1939 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2025 | 8635 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 2406 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2602 | 0.070 |
Why?
|
| Adult | 2 | 2025 | 31282 | 0.060 |
Why?
|
| Mice | 4 | 2020 | 18301 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3819 | 0.050 |
Why?
|
| Neuregulin-1 | 1 | 2020 | 13 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4738 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2020 | 41 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2020 | 34 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2020 | 114 | 0.040 |
Why?
|
| Antigens, Ly | 1 | 2020 | 31 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 96 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2020 | 131 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 155 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 165 | 0.040 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2019 | 22 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2020 | 243 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 645 | 0.040 |
Why?
|
| Eosinophils | 1 | 2019 | 122 | 0.030 |
Why?
|
| Humans | 3 | 2025 | 131163 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2020 | 674 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2326 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2465 | 0.020 |
Why?
|
| Lung | 1 | 2020 | 1535 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4497 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6797 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3436 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 2332 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 10103 | 0.010 |
Why?
|
| Male | 2 | 2020 | 64957 | 0.010 |
Why?
|
| Female | 2 | 2020 | 70963 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21025 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 20987 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17753 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28601 | 0.010 |
Why?
|